SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: Miljenko Zuanic who wrote (2678)4/8/2019 1:24:07 PM
From: DewDiligence_on_SI  Read Replies (1) | Respond to of 3557
 
Who knows if these candidates will pan out? At least REGN is doing something to prepare for the day when Eylea is no longer a big-selling drug. (REGN retains primary responsibility for the ophthalmic component of the ALNY deal.)



To: Miljenko Zuanic who wrote (2678)4/12/2019 8:50:04 PM
From: Felix B  Read Replies (1) | Respond to of 3557
 
Always appreciate your posts Miljenko!

Just curious, can you explain more on no failed partnerships? What about Avalanche/Advernum?